The Anti-nonGal xenoantibody response to α1,3-galactosyltransferase gene knockout pig xenografts

Current Opinion in Organ Transplantation

Volumn 15, Issue 2, 2010, Pages 207-211

  Harnden, Ivan ^a   Kiernan, Kathleen ^a   Kearns Jonker, Mary ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

1; 3 galactosyltransferase gene knockout; 3gal carbohydrate; Gala1; Xenotransplantation

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; ANNEXIN; CD59 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4D; COMPLEMENT MEMBRANE ATTACK COMPLEX; DECAY ACCELERATING FACTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRONECTIN; FUCOSYLTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M; VIMENTIN;

ANTIBODY RESPONSE; ANTIBODY STRUCTURE; ENDOTHELIUM CELL; GENETIC MANIPULATION; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; HUMORAL IMMUNITY; IMMUNOGENETICS; NONHUMAN; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN EXPRESSION; REVIEW; SWINE; TRANSPLANTATION TOLERANCE; XENOTRANSPLANTATION;

AMINO ACID SEQUENCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIBODIES, HETEROPHILE; ANTIGENS, HETEROPHILE; ENDOTHELIAL CELLS; GALACTOSYLTRANSFERASES; GENE KNOCKOUT TECHNIQUES; GENES, IMMUNOGLOBULIN HEAVY CHAIN; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNITY, HUMORAL; MOLECULAR SEQUENCE DATA; SPECIES SPECIFICITY; SWINE; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HETEROLOGOUS; TRISACCHARIDES;

EID: 77952257682     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e328336b854     Document Type: Review

References (37)

1. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1, 3-galactosyl-transferase-deficient pigs. Science 2003;299:411-422.
2. Lai L, Kolber-Simonds D, Park KW, et al. Production of alpha-1, 3-galactosyl-transferase knockout pigs by nuclear transfer cloning. Science 2002;295: 1089-1092. (Pubitemid 34132242)
3. Nottle MB, Beebe LFS, Harrison SJ, et al. Production of homozygous a 1, 3 galactosyltransferase knockout pigs by breeding and somatic cell nuclear transfer. Xenotransplantation 2007;14:339-344.
4. Chen G, Qian H, Starzl T, et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005;11:1295-1298. (Pubitemid 41752909)
5. Yamada K, Yazawa K, Shimizu A, et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1, 3-galactosyltransfer-ase gene-knockout donors and the co-transplantation of vascularized thymic tissue. Nat Med 2005;11:32-34. (Pubitemid 40215834)
6. Kuwaki K, Tseng YL, Dor FL, et al. Heart transplantation in baboons using alpha1, 3-galactosyltransferase gene-knockout pigs as donors: Initial experience. Nat Med 2005;11:29-31. (Pubitemid 40215833)
7. Tseng YL, Kuwaki K, Dor FJ, et al. Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching six months. Transplantation 2005;80:1493-1500. (Pubitemid 41803633)
8. Shimizu A, Hisashi Y, Kuwaki K, et al. Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1, 3-galactosyltransferase gene-knockout pigs in baboons. Am J Pathol 2008;172:1471-1481. This study is the first report to provide a detailed account of the disorder associated with the rejection of GalT-KO cardiac xenografts in baboons. (Pubitemid 351793341)
9. Hisashi Y, Yamada K, Kuwaki K, et al. Rejection of cardiac xenografts transplanted from α1, 3 galactosyltransferase gene-knockout (GalT-KO) pigs to baboons. Am J Transplant 2008;8:2516-2526. (Pubitemid 351793341)
10. Ezzelarab M, Garcia B, Azimzadeh A, et al. The innate immune response and activation of coagulation in α1, 3 galactosyltransferase gene-knockout xenograft recipients. Transplantation 2009;87:805-812. This study shows that the innate immune system plays a role in the rejection of GalT-KO xenografts.
11. Kiernan K, Harnden I, Gunthart M, et al. The anti-nonGal xenoantibody response to xenoantigens on gal knockout pig cells is encoded by a restricted number of germline progenitors. Am J Transplant 2008;8:1829-1839. This study defines the structure and sequence of immunoglobulin genes encoding anti-nonGal xenoantibodies and shows that iGb3 synthase is not expressed in GalT-KO pig cells.
12. Rood P, Tai HC, Hara H, et al. Late onset of development of natural anti-nonGal antibodies in infant humans and baboons: implications for xenotransplantation in infants. Transpl Int 2007;20:1050-1058. (Pubitemid 350043843)
13. Hara H, Long C, Lin YJ, et al. In vitro investigation of pig cells for resistance to human antibody-mediated rejection. Transpl Int 2008;21:1163-1174.
14. Saethre M, Baumann BC, Fung M, et al. Characterization of natural human anti-non-gal antibodies and their effect on the activation of porcine gal deficient endothelial cells. Transplantation 2007;84:244-250. (Pubitemid 47205759)
15. Cowan P, d'Apice A. Complement activation and coagulation in xenotransplantation. Immunol Cell Biol 2009;87:203-208.
16. Dwyer KM, Robson SC, Nandurkar HH, et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 2004;113:1440-1446.
17. Li SZ, Qu YC, Liu BQ, et al. Synergistic effects of α1, 2 fucosyltransferase, DAF and CD59 in suppression of xenogeneic immunological responses. Xenotransplantation 2009;16:27-33. This study shows that multiple genetic modifications are beneficial for minimizing immune responses to xenografts.
18. Kelishadi SS, Zhang T, Stoddard T, et al. Addition of hDAF to the Gal-KO background improved survival and function of pig kidneys in baboons. Am J Transplant 2008;8 (Suppl 2) : 205. (abstract #97).
19. Murray-Segal L, Gock H, Cowan PJ, et al. Anti-Gal antibody-mediated skin graft rejection requires a threshold level of Gal expression. Xenotransplantation 2008;15:20-26. (Pubitemid 351360236)
20. Byrne GW, Stalboerger PG, Davila E, et al. Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation. Xenotransplantation 2008;15:268-276.
21. Irie A, Suzuki A. CMP-N-acetylneuraminic acid hydroxylase is exclusively inactive in humans. Biochem Biophys Res Commun 1998;248:330-333. (Pubitemid 28386421)
22. Milland J, Christiansen D, Lazarus BD, et al. The molecular basis for Galα1, 3 Gal expression in animals with a deletion of the α1, 3galactosyltransferase gene. J Immunol 2006;176:2448-2454. (Pubitemid 43201695)
23. Diswall M, Angstrom J, Schuurman HJ, et al. Studies on glycolipid antigens in small intestine and pancreas from alpha1, 3 galactosylransferase knockout miniature swine. Transplantation 2007;84:1348-1356. (Pubitemid 351339324)
24. Diswall M, Angstrom J, Schurman HJ, et al. Glycolipid studies in small intestine and pancreas of a1, 3 galactosylransferase knockout miniature swine:α1, 3-GalTKO animals lack αGal antigens and contain novel blood group H compounds. Transplant Proc 2008;40:543-546. The authors use proton NMR spectroscopy to show that GalT-KO pig tissues lack αGal antigens but express two novel, branched blood group H compounds. (Pubitemid 351406423)
25. H3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit. Infect Immun 2003;71:4313-4319. (Pubitemid 36919894)
26. Arnaout R. Specificity and overlap in gene segment-defined antibody repertoires. BMC Genomics 2005;6:148. (Pubitemid 41631795)
27. Bible JM, Howard W, Robbins H, Dunn-Walters DK. IGHV1, IGHV5 and IGHV7 subgroup genes in the Rhesus macaque. Immunogenetics 2003;54:867-873. (Pubitemid 36470081)
28. Link JM, Hellinger MA, Schroeder HW Jr. The rhesus monkey immunoglobulin IGHD and IGHJ germline repertoire. Immunogenetics 2002;54:240-250.
29. Zahorsky-Reeves JL, Kearns-Jonker MK, Lam TT, et al. The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts. Xenotransplantation 2007;14:135-144.
30. H gene usage in rhesus monkeys and humans exposed to porcine hepatocytes. BMC Immunol 2006;7:3.
31. H genes encoding xenoantibodies in nonimmunosuppressed rhesus monkeys. Immunology 2005;116:89-102. (Pubitemid 41208356)
32. Kearns-Jonker M, Barteneva N, Mencel R, et al. Use of molecular modeling and site-directed mutagenesis to define the structural basis for the immune response to carbohydrate xenoantigens. BMC Immunol 2007;8:3. (Pubitemid 46579172)
33. Nozawa S, Xing PX, Wu GD, et al. Characteristics of immunoglobulin gene usage of the xenoantibody binding to Gal-alpha (1, 3) Gal target antigens in the gal knockout mouse. Transplantation 2001;72:147-155. (Pubitemid 32652521)
34. Agostino M, Sandrin MS, Thompson PE, et al. In silico analysis of antibody-carbohydrate interactions and its application to xenoreactive antibodies. Mol Immunol 2009;47:233-246. This study describes a site mapping technique that identifies specific amino acids within the light chain, heavy chain and CDR3 that are predicted to be important for antigal xenoantibody-carbohydrate interactions.
35. Yuriev E, Agostino M, Farrugia W, et al. Structural biology of carbohydrate xenoantigens. Expert Opin Biol Ther 2009;9:1017-1029.
36. Kimura H, Umeda M, Marcus DM. Expression of a cross-reactive idiotope on naturally occurring antibodies against 3-fucosyllactosamine, levan and dextran. J Immunol 1989;142:3477-3481. (Pubitemid 19137477)
37. Schoonbroodt S, Steukers M, Viswanathan M, et al. Engineering antibody heavy chain CDR3 to create a phage display Fab library rich in antibodies that bind charged carbohydrates. J Immunol 2008;181:6213-6221.